Abstract. Mutations in the SAC1 gene exhibit allelespecific genetic interactions with yeast actin structural gene defects and effect a bypass of the cellular requirement for the yeast phosphatidylinositol/phosphatidylcholine transfer protein (SEC14p), a protein whose function is essential for sustained Golgi secretory function. We report that SAClp is an integral membrane protein that localizes to the yeast Golgi complex and to the yeast ER, but does not exhibit a detectable association with the bulk of the yeast F-actin cytoskeleton. The data also indicate that the profound in vivo effects on Golgi secretory function and the organization of the actin cytoskeleton observed in sad mutants result from loss of SAClp function. This cosuppression of actin and SEC14p defects is a unique feature of sad alleles as mutations in other SAC genes that result in a suppression of actin defects do not result in phenotypic suppression of SEC14p defects. Finally, we report that sac1 mutants also exhibit a specific inositol auxotrophy that is not exhibited by the other sac mutant strains. This sad-associated inositol auxotrophy is not manifested by measurable defects in de novo inositol biosynthesis, nor is it the result of some obvious defect in the ability of sad mutants to utilize inositol for phosphatidylinositol biosynthesis. Thus, sac1 mutants represent a novel class of inositol auxotroph in that these mutants appear to require elevated levels of inositol for growth. On the basis of the collective data, we suggest that SAClp dysfunction exerts its pleiotropic effects on yeast Golgi function, the organization of the actin cytoskeleton, and the cellular requirement for inositol, through altered metabolism of inositol glycerophospholipids.
result in phenotypic suppression of SEC14p defects. Finally, we report that sac1 mutants also exhibit a specific inositol auxotrophy that is not exhibited by the other sac mutant strains. This sad-associated inositol auxotrophy is not manifested by measurable defects in de novo inositol biosynthesis, nor is it the result of some obvious defect in the ability of sad mutants to utilize inositol for phosphatidylinositol biosynthesis. Thus, sac1 mutants represent a novel class of inositol auxotroph in that these mutants appear to require elevated levels of inositol for growth. On the basis of the collective data, we suggest that SAClp dysfunction exerts its pleiotropic effects on yeast Golgi function, the organization of the actin cytoskeleton, and the cellular requirement for inositol, through altered metabolism of inositol glycerophospholipids.
T HE Golgi complex plays a fundamental role in the regulation of key aspects of intracellular protein and membrane traffic through the eukaryotic secretory pathway. As a result, considerable effort has been directed at the development of powerful biochemical and molecular strategies to identify the factors that govern the secretory functions of this organelle. In Saccharomyces cerevisiae, the SEC14 gene product (SEC14p) is required for secretory protein transport from a late Golgi compartment (Novick et al., 1980; Franzusoff and Schekman, 1989) . We have established that SEC14p is a peripheral membrane protein of the yeast Golgi whose function is essential for cell viability and whose structure is highly conserved across significant phylogenetic boundaries Cleves et al., 1991a, b; Salama et al., 1990; H.B. Skinner and V.A. Bankaitis, manuscript in preparation) . Moreover, we have demonstrated SECI4p to be the yeast phosphatidylinositol E. A. Whitters and A. E. Cleves contributed equally to this study and represent co-first authors.
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To date, the most penetrating insights into the mechanism of SEC14p function have been obtained from a detailed analysis of yeast mutants in which the normally essential cellular requirement for SECI4p is bypassed. It was demonstrated that mutations in any one of at least six genes could effect an efficient bypass of SEC14p, and it was further recognized that such alleles of three of these genes block PC biosynthesis via the CDP-choline pathway (Cleves et al., 1991b) . On the basis of those data, we proposed that SEC14p functions to establish a critical phospholipid composition in Golgi membranes that is required for Golgi secretory competence. Bypass alleles of the remaining three genes (i.e., BSD1, BSD2, and SAC1) do not block PC synthesis via the CDP-choline pathway, however, and analysis of these genes is expected to yield novel insights into SEC14p function in vivo. One of these genes, SAC1, is of singular interest. Not only do sad alleles effect an efficient bypass of the SEC14p requirement, but these same alleles also suppress mutations in ACT/, the actin structural gene of yeast, in an allelespecific manner (Cleves et al., 1989; Novick et al., 1989) . These findings have identified a previously unanticipated relationship between the organization of the actin cytoskeleton and the function of a Golgi-specific phospholipid transfer protein in vivo, and raise the issue of what role SAClp plays in this relationship.
In this report, we show that SAClp is an integral membrane protein that localizes both to the yeast Golgi complex and to the yeast ER, but does not detectably associate with the bulk filamentous actin cytoskeleton in yeast. Moreover, we establish that it is loss of SAClp function that effects the bypass of SEC14p. Finally, we demonstrate that sad mutations are unique among the other known sac mutations in their ability to suppress both sec14-associated Golgi defects and defects in actin cytoskeleton function, and that sacl alleles are similarly unique in their phenotypic manifestation of a specific inositol auxotrophy in yeast. We offer the general hypothesis that the pleiotropic phenotypes associated with SAClp dysfunction reflect alterations in some aspect of inositol glycerophospholipid metabolism in sad yeast strains.
Materials and Methods

Strains, Media, and Reagents
Complete genntypes of yeast strains and description of plasmids are listed in Table I . YP, yeast minimal and defined media have been described (Sherman et al., 1983) . Yeast minimal media that either lack or contain inositol (lmM) and choline (lmM) were described by Klig et al. (1985) . Con A-sepharose, TRITC-eonjugated phalloidin, poly-L-lysine, DAlai, indoleacrylic acid, PMSF, chymostatin, pepstatin, leupeptin, sodium pyrophosphate, myo-inositol dehydrogenase, and proteinase K were obtained from Sigma Immunochemieals (St. Louis, MO). The NADH monitoring kit was purchased from LKB-Wallac (Gaithersburg, MD), and NAD was obtained from Boehringer Mannheim Biochemicals (Indianapolis, IN). Protein G-Sepharose was from Pharmacia Fine Chemicals (Piscataway, NJ). Intermediate and secondary antibodies conjugated to fluorochrome were from Jackson ImmunoResearch (West Grove, PA). Reagents for SDS-PAGE were from Bio-Rad Laboratories (Richmond, CA).
[35S]-labeled amino acids were purchased under the [35S]Trans-Label trademark (>1,000 Ci/mmol) from ICN Radiochemicals (Irvine, CA). Oxalyticase was from Enzogenetics (Corvallis, OR). Proteinase A antiserum was obtained from E. W. Jones (Carnegie Mellon University, Pittsburgh, PA). The YEp(KEX2) plasmid and KEX2p antiserum were obtained from R. Fuller (Stanford University Medical Center, Stanford, CA). Yeast aetin antiserum was obtained from D. Drubin (University of California, Berkeley, CA) and B. Haarer (University of Michigan, Ann Arbor, MI).
SAClp Antibodies
pRE102, a plasmid consisting of a 2.4-kb XbaI SAC1 minimal complementing fragment subcloned in the vector pTZISU (Cleves et al., 1989) , was MAT a, ura3-52, z~is3-200, lys2-801, sec14-1, sacl-26 Cleves et al. (1989) MAT a, ura3-52, Ahis3-200, lys2-801 Bankaitis et al. (1989) CTY214 MAT a, 112, This study CTY234~ CTY182/pCTY136 This study CTY244 MAT a, digested with BclI and religated. This resulted in a deletion of the internal 527-bp BclI fragment from the SAC1 clone. The deletion of the BclI fragment caused a frame shift within the SAC1 coding sequence such that the unique BclI site was followed by five new codons (the first two of which fortuitously encoded the same amino acids in those positions as the authentic SAC1 sequence) and a stop codon. The ABclI plasmid (pRE138) encodes the first 356 residues of the SACIp plus three new residues. Using the XhoI site within the SAC1 gene and the Sinai site in the vector polylinker, a 1.5-kb XhoLSmaI fragment that encodes SACIp amino acids 102-356 (plus three new residues) was removed from pREI38 and subcloned into the SalI and HindIII (blunt-ended) polylinker sites of pATH10 (from A. Tzagaloff), an inducible expression vector that contains the promoter, operator, and coding sequence for the trpE gene. The resultant plasmid, pREI39, encodes a 593 residue fusion protein representing amino acids 102-356 of the SAClp (68 kD). E. coli strain RRI (Bolivar et al., 1977) bearing pRE139 produced some 10 mg of fusion protein per liter of cells after an 8-h expression period in tryptopban-free medium supplemented with indoleacrylic acid (20 /zg/ml). The hybrid protein was purified via a general procedure for TrpE fusion proteins (Kleid et al., 1981) and found to reside in the supernatant of a 0.1% SDS, 50 mM Tris, pH 7.5, 50 mM EDTA wash oftbe insoluble fraction of the total cellular lysate, mAbs were generated by standard methods (Kennett, 1980) . Balb/C mice were given a primary and two boost injections of 50/~g of fusion protein per injection. Hybridoma cell lines were produced and maintained in the Hybridoma Facility, University of Illinois Biotechnology Center (Urbana, IL). Culture supernatants from the hybridomas were screened for anti-SAClp antibodies by immunoprecipitation assays of radiolabeled yeast lysates. Two positive clones, hybridoma cell lines C5 and C6, were amplified in cell culture and the antiSAClp mAbs were precipitated from culture supernatants by addition of (NI-L,)2SO4 to 50% saturation. For immunoprecipitation (IP) and immunolocalization of SAClp, a mixture of these two mAbs was used.
Identification of SAClp
Radiolabeling of yeast with 35S-Trans label and preparation of clarified extracts was performed as described by Bankaitis et al. (1989) . Immune complexes were recovered with protein G-Sepharose and sequentially washed twice with IP buffer (50 mM Tris-Cl, pH 7.5, 150 mM NaCI, 0.1 mM EDTA, 0.5% Tween 20), twice with urea wash buffer (2 M urea, 100 mM Tris-Cl, pH 7.5, 200 mM NaCI, 0.5 % Tween 20), and twice with 0.1% SDS. Resolution of the immunoprecipitates and autoradiography was performed as described by Schauer et al. (1985) . For immunoprecipitations, SAClp and PrA antibodies were used at final concentrations of 3.3 pg/ml and 8/zg/ml, respectively.
Fractionation of SAClp
Whole cell (WC), low speed pellet (LSP), 12,000 g pellet (P12), 100,000 g pellet (PI00), and 100,000 g supernatant (S100) fractions derived from radiolabeled CTY182 were prepared exactly as described by Bankaitis et al. (1989) . Clarified extracts derived from each fraction were treated with PrA and SAClp antibodies.
Na2C 0 3 Extraction
Strain CTY150 (ODtoo --1.0) was radiolabeled for 1 h (100 pCi Translabel/ml). After termination of radiolabel incorporation by the addition of NaN3 to 10 mM, the cells were washed twice in 10 mM NaN3 and then converted to spheroplasts by a 20 rain incubation at room temp in 1.4 M sorbitol, 50 mM KPi, pH 7.5, 10 mM NAN3, 20 ~g/rnl oxalyticasc. The spheroplasts were pelleted gently in a clinical centrifuge and subjected to osmotic lysis by resusponsion in 1.0 ml 0.3 M sorbitol, 10 mM MOPS, pH 7.0. Uulysed cells and large debris were removed by centrifugation at 500 g for 2 min. Subsequently, 0.5 ml of clarified lysate was removed and saved as the WC fraction. The remaining 0.5 ml was adjusted to 0.1 M Na2CO3, pH 11.5, and incubated on ice for 1 h. The sample was then spun at 100,000 g for 1 h yielding the high speed supornatant (S100) and high speed pellet (Pl00) fractions. The PI00 was sohibilized in 1% SDS buffer (50 mM Tris, pH 7.5, 1 mM EDTA, 1% SDS). TCA (5% final concentration) was used to precipitate proteins from the WC and SI00 fractions, and these precipitates were solubllized in 1% SDS buffer. The WC, S100, and PI00 fractions were then diluted in IP buffer and treated with SEC14p antiserum (8/tg/ml final concentration) and SAClp antibodies.
Immunoprecipitation of SAClp from sacl c" Mutants
Cultures of wild type and sad cs strains (OD60o = 1.0) were radiolabeled for either 1 h or 5 min with [35S]Trans-label (100/zCi/ml). The corresponding extracts were subjected to immunoprecipitation with SEC14p and SACIp antisera by the regimen described above.
Immunofluorescence
Yeast strains were grown to an early logarithmic stage of growth in complete minimal medium or uracil-deficient medium for plasmid maintenance. Yeast were prepared for immunofluorescence essentially as described by Pringle et al. (1989) . Cultures were fixed with 4% formaldehyde (final concentration) first for 15 min in the culture medium and then for 12 h at 4°C in 100 mM potassium phosphate, pH 6.5, 0.5 mM MgC12 (buffer A). The fixed cells were spheroplasted for 30 min at 37°C in buffer A containing 20 #g/ml oxalyticase followed by four washes in Ix PBS. Washed spheroplasts were placed on poly-L-lysine-coated glass slides and subsequently immersed in methanol (-20°C) for 6 min, and then acetone (-20°C) for 1 min. All incubations and washes were performed at room temp in lx PBS, 1% BSA. After the final washes, one drop of 1 mg/ml p-phenylenediamine (in 90% glycerol, 0.1x PBS) was added to the stained cells which were then sealed under glass coverslips. The samples were photographed using TMAX 400 film (Eastman Kodak Co., Rochester, NY) and a Zeiss axioplan microscope (Carl Zeiss, Inc., Thornw~xl, NY) equipped for fluorescence with UV filters and an HBO 50-W mercury lamp. Antibody incubations for localization of the SACIp were: (a) anti-SAClp antibodies (16 ttg/ml final concentration), 2 h; (b) 15/~g/ml rabbit anti-mouse IgG or sheep anti-mouse IgG, 1 h; and (c) 15 /Lg/ml FITC-conjugated goat anti-rabbit IgG or TRSC-conjugated donkey anti-sheep IgG, I h. Antibody incubations for localization of the KEX2p were: (a) afffinity-purified polyclonal rabbit anti-KEX2p serum (preadsorbed against permeabilized Akex2 spheroplasts, 30/zg/ml final antibody concentration), 2 h; and (b) 15/zg/ml FITC-conjugated goat anti-rabbit IgG, 1 h. For the co-localization of actin and the SAClp, fixed spheroplasts were permeabilized by a 20-min incubation in 1% Triton X-100, lx PBS, washed four times in PBS, and then placed on polylysine-coated glass slides and allowed to air dry. Actin was visualized using TRITC-conjngated phalloidin (6.6 pM final concentration).
SubceUular Fractionation
Preparation of highly enriched Golgi fractions was performed as described by Cleves et al. (1991b) with minor modifications. The sorbitol gradients described in this work were 40-65% for the first gradient and 50-60% for the second gradient. Resolution of the 12,000 g pellet fractions, generated by the method of Cleves et al. (1991b) , was performed by equilibrium flotation in a self-forming 30-55% sucrose gradient essentially as described by Bowser and Novick (1991) . 0.5-mi fractions were collected from the top of the gradient and assayed for the appropriate markers.
Construction of a sac7Al: : URA3 Null Allele
We generated a sac7AI::URA3 allele that is directly analogous to the sacZ': LEU2 null allele previously reported by Dunn and Shortle (1990) to represent an allele-specific suppressor of actl ~. Oligonucleotides SAC7-SA (5'CCC_,AATICGGTACCAAATICAACGATTGG-39 and SACT-3B (5'CCGCATC~CCCGGTTrATGTAACCAC~-3') were used as forward and reverse primers, respectively, to generate an '~l-kb PCR product from a template of yeast genomic DNA. The extreme 5' end of this PCR product spans the Kpnl site that is situated immediately upstream of the SAC7 gene, and the 3' end of this product corresponds to the COOH-terminal coding region of SAC7 (see Dunn and Shortle, 1990 ). This PCR product was subcloned into a AHindIII derivative ofpTZ18R as an EcoRI-SphI restriction fragment to yield pRE176. This resultant plasmid was then digested with Hincll to release a 480-bp fragment, resulting in a deletion in the plasmid of essentially all of the coding sequence for the minimal SAC7p functional domain (Dunn and Shortle, 1990) , the resultant blunt ends were ligated to HindIII linkers, and the yeast URA3 gene was inserted into that newly created HindIII site to generate the sac7AI::URA3 plasmid pRE180. The disruption allele was excised as a 1.5-kb KpnI-SphI fragment and used to transform strain CTYI-IA to Ura +. The authenticity of the sac7AI::URA3 transformants was confirmed by diagnostic PCR.
Measurement of lntraceUular Inositol Pools
The appropriate yeast strains were grown to mid-logarithmic phase (OD600 = 1.0-1.2) at 300C with shaking in the defined minimal media of Klig et al. (1985) supplemented with inositol and choline to a final concentration of 1 mM each (FC + medium). Cells were harvested by centrifugation, washed four times with the same medium lacking inositol and choline (I-C-medium), and resuspended in 3 ml of I-C-medium for continued incubation at 30"C with shaking. Samples (1.5 ml) were either removed immediately after resuspension in I-C-medium, or 3 h after resuspension, to yield the 0 and 180 rain time point samples, respectively. For each sample, cells were pelleted in an Eppendorf tube, resuspeuded in 50/~1 of bnifer I (50 mM Tris-HCL, pH 7.4, 20% glycerol, 1 mM EDTA), glass beads (0.2-0.3 mM diana) were added to '~75% of volume, and the tubes were chilled on ice. Each tube was then vortexed ten times in 30-s bursts with a 1-min rest with cooling between bursts. The lysates were clarified by centrifugation for 15 rain at 14,000 g and supernatants collected for protein and inositol assay.
Inositol was quantitated by a modification of an enzyme-coupled bioluminescence assay developed by Gudermann and Cooper (1986) . Briefly, the 80 ~1 inositol assay cocktail included 50 t~l distilled H20, 13/~1 sodium pyrophosphate (0.1 M, pH 9.0), 8/~1NAD (5 raM), 1.4/~1 myo-inositol dehydrogenase (1.5 mU/t~l), and 8 t~l of either an appropriate dilution of lysate in distilled I-I20 (to yield an input of 0.1 t~g of protein into the reaction) or a known inositol standard. The reaction was incubated at 25"C for 5 min after which time 80 ~1 of NADH monitoring reagent, prepared according to the method of Gudermann and Cooper (1986) , was added to each assay. Luminescence was monitored immediately, and recorded as a time course over a 5-rain period at 20-s intervals using a Lumiphot luminometer. Inositol content of each sample was calculated by determining the initial rates of increase in luminescence vs time, and comparing these rates to those established for samples of known inositol content as described by Gutermann and Cooper (1986) . Protein concentrations were determined by the bicinchoninic acid (BCA) assay marketed by Pierce Bioehemicals.
Phospholipid Analyses
The appropriate yeast strains were grown to an ODt00 of ,,00.8, total glycerophospholipid was extracted and resolved by ~>-dimensional paper chromatography exactly as described by Atkin~n (1984) . Resolved phospholipid species were stained with Rhodamine 6G and visualized under UV light (Christie, 1987) . Individual phospholipid species were excised and the lipids extracted from the paper with chloroform/methanol (2:1) for 15 rain and dried in vacuo. Quantitation of phosphate was performed by the method of Ames (1966) .
Results
Identification of the SAClp
Nucleotide sequence analysis of SAC1 identified an open reading frame with the potential to encode a 623 residue polypeptide with a predicted molecular mass of some 71 kD (Cleves et al., 1989) . We used this nucleotide sequence information to engineer the high level production of a TrpESAClp fusion protein in E. coli which was then partially purified and used as immunogen for the generation of mouse mAbs (see Materials and Methods). To identify SAClp, the appropriate yeast strains were radiolabeled with [35S]-labeled amino acids for 30 min at 25"C, and SAClp immunoreactive species were precipitated from the corresponding clarified extracts with a mixture of these two monoclonal antisera (see Materials and Methods). Vacuolar proteinase A (PrA) antigen, a control glycoprotein, was also monitored in these experiments so as to normalize the SAClp data. The immunoprecipitates were resolved by SDS-PAGE and evaluated by autoradiography.
As the data in Fig. 1 (lane B) show, two labeled species were recovered from wild-type yeast lysates treated with both SAClp and PrA antibodies: a 65-kD species and the 43-kD PrA. The 65-kD species was not recovered from wildtype lysates when preimmune serum was substituted for SAClp antibodies in the precipitation assay (Fig. 1, lane A) , nor was it recovered when SAClp and PrA antibodies were reacted with lysate prepared from a ~sacl strain (Fig. 1 , lane C). Substantially increased m o u n t s of the 65-kD species (relative to PrA) were recovered from extracts prepared from a yeast strain carrying SAC1 on a multicopy plasmid; a strain expected to overproduce the SAClp (Fig. 1, lane D) . By densitometry, we estimate this level of overproduction to be approximately 20-fold relative to wild-type levels. Finally, pretreatment of wild-type yeast lysate with E. coli extract containing the TrpE-SAClp fusion protein, against which the SAClp antibodies were raised, specifically competed precipitation of the 65 kD species (Fig. 1, lane F) . Challenge of the same wild-type lysate with an equivalent amount of E.
coli extract that was devoid of SAClp antigen exerted no such competitive effect (Fig. I , lane E). The combined data demonstrate that the 65-kD species represents the SAClp. Further confirmation of this conclusion is presented in Fig. 8 A where we show that several sad c, alleles encode what appear to be truncated forms of SAClp (see below). In vivo radiolabeling experiments (coupled with quantitative immunoprecipitation, SDS-PAGE, autoradiography, quantitation by laser densitometry, and consideration of the rather modest differences in the sulfur-containing amino acid content of these two proteins) suggest that the SEC14p is some 15-20-fold more abundant than the SAClp (See Fig. 3 B, lane 2). Since SEC14p represents a moderately abundant yeast cell protein (ca. 0.03% of total cell protein; Bankaitis et al., 1989) , the data identify the SAClp as a rather inabundant yeast protein.
To determine whether the SAClp is a glycoprotein, cellfree lysates prepared from the SAClp-overproducing strain were incubated with Con A-coated Sepharose beads, Con A-precipitable and supernatant fractions were generated, SAClp and PrA were precipitated from each fraction, and the corresponding immunoprecipitates were evaluated by SDS-PAGE and autoradiography. As shown in Fig. 1 (lane G), PrA exhibited the expected behavior for a glycoprotein and was recovered only from the Con A-bound fraction. By contrast, SAClp failed to bind the Con A beads and was recovered only from the supernatant fraction (Fig. 1, lane H) . Taken together, these data demonstrate that SAClp is an unglycosylated polypeptide, with an apparent molecular mass of some 65 kD, that is expressed at rather low levels in wildtype yeast cells.
The SAClp Is An Integral Membrane Protein
Inspection of the inferred SAClp primary sequence reveals a run of 23 uncharged amino acids, extending from residue 522 to residue 544, that constitutes a potential membranespanning domain (Cleves et al., 1989) . To determine if SAClp is membrane associated, we used a differential centrifugation regimen to resolve radiolabeled cell-free lysates into various membrane-enclosed and cytoplasmic fractions (see Materials and Methods). These fractions were then probed for SAClp immunoreactive materials by quantitative immunoprecipitation with SAClp mAb. PrA was also immunoprecipitated from these fractions. The conditions of radiolabeling were such that a significant percentage of the total radiolabeled PrA was recovered in the pl and p2 forms of the enzyme. These forms of the PrA zymogen served as soluble lumenal markers for the ER and early Golgi, and late Golgi compartments, respectively (Klionsky et al., 1988) .
As shown in Fig. 2 A, the pl and p2 forms of PrA were nearly quantitatively recovered from the 12,000 g (P12) and 100,000 g (P100) pellet fractions, and no detectable amounts ofpl or p2 PrA were recovered from the 100,000 g supernatant (S100; i.e., cytoplasmic) fraction. These data indicate that the cell lysis procedure preserved the integrity of the yeast ER and Golgi. SAClp exhibited a fractionation profile that was very similar to that observed for pl and p2 PrA. That is, SAClp quantitatively sedimented with membranes, and was roughly equally distributed between the P12 and P100 fractions (Fig. 2 A) . These data, coupled with our findings that SAClp floats in equilibrium flotation gradients (see below), demonstrate an association of SAClp with yeast membranes and rule out the possibility that the SAClp simply pellets as a large protein aggregate.
To investigate the membrane association properties of SAClp, we determined whether alkaline pH treatment releases SAClp from membranes (Fugiki et al., 1982) . In these experiments we used strain CTY150, the SAClp overproducing strain, to facilitate detection of the SAClp. SEC14p served as a peripheral membrane protein/cytosolic protein control . As expected, SEC14p was efficiently extracted by the alkaline treatment and was recovered only from the S100 fraction (Fig. 2 B) . By contrast, SAClp was recovered exclusively from the P100 fraction. Identical SAClp extraction profiles were obtained when these experiments were performed with wild-type yeast strains (data not shown), thereby indicating that the membrane-association properties of SAClp are not altered when the polypeptide is overproduced. In other experiments, we found that the majority (ca. 80%) of the SAClp partitioned Figure 2 . Membrane association properties of SACIp. (A) Differential centrifugation. Strain CTY182 (SAC1) was radiolabeled and the resulting osmotic lysate was subjected to three rounds ofcentrifugation (see Materials and Methods). The whole cell (WC), 12,000 g pellet (P12), 100,000 g supernatant (SIO0), and 100,000 g pellet (PIO0) fractions were probed for the presence of precursor forms of PrA and SAClp. The pl and p2 PrA, indicated at left, serve as lumenal markers for ER and early Golgi, and late Golgi, compartments, respectively. Note that the WC fraction was derived from one-half of the material that was used to generate the other fractions (see Materials and Methods). Our recoveries of antigen after fractionation typically exceeded 85 %. (B) Alkaline nonextractability of SAClp. The SACIp overproducing strain CTY150 was radiolabeled and an osmotic lysate was prepared. One-half of that cell-free lysate was saved as the whole cell (WC) fraction and the remainder was adjusted to 0.1 M Na2CO3 (pH 11.5). After a 1-h incubation on ice, the Na2CO3 fraction was centrifuged at 100,000 g and the resulting S100 and P100 fractions were probed for the presence of SAClp and SEC14p, a peripheral membrane protein control.
into the detergent phase upon solubilization of osmotic lysates with Triton X-114 and subsequent resolution of aqueous and detergent phases (data not shown). These data indicate that SAClp is an integral membrane protein.
Localization of the SAClp by Immunofluorescence
To detect SAClp by immunofluorescence methods, we used an antibody sandwich method that had previously been successfully applied to the localization of other inabundant yeast proteins (Pringle et al., 1989) . Visualization of the SAClp staining profile of wild-type yeast cells revealed a faint, but reproducible, punctate pattern (Fig. 3 A, lane 2) . Further ex-amples of this SAClp staining profile are shown in Figs. 4 and 5. We generally observed between three and eight FITCstained bodies per cell in any given focal plane, and >90 % of the yeast cells exhibited this pattern. This punctate staining was not associated with either the nucleus or the mitochondria, as judged by the lack of colocalization of FITCstained structures with DAPI-stained structures (Fig. 3 A,  lane 2) . We address the identity of these punctate structures below. Moreover, we occasionally found cells that, in addition to the punctate staining, also exhibited what appeared to be a fainter nuclear envelope staining for SAClp. An example of such SAClp staining is presented in Fig. 4 (panel 2). Those punctate and nuclear envelope SACIp staining profiles are considered to reflect the authentic distribution of the SAClp as sac1 ° yeast strains failed to exhibit any detectable FITC-staining under these experimental conditions (Fig. 3 A, lane 1 ) . Furthermore, preincubation of 3AClp antibodies with TrpE-SAClp fusion protein, but not TrpE anti- Figure 3 . Localization of SAClp. (A) Immunofluorescence localization of SAClp. Fixed yeast cells were permeabilized and stained for SAClp using an antibody sandwich consisting of primary anti-SAClp mouse mAbs, secondary rabbit anti-mouse IgG serum, and tertiary goat anti-rabbit IgG conjugated to fluorescein isothiocyanate (FITC). Nuclei and mitocbondria were stained with the DNA stain DAPI. Isogenic yeast strains engineered to produce varying relative amounts of SACIp were employed in these experiments. Lane 1, strain CTY463 (Asad); lane 2, strain CTY182 (SAC/); lane 3, strain CTY444 (YEp SAC1); lane 4, strain CTY443 (YCp SAC1). The YEp(SAC1) plasmid in strain CTY444 (i.e., pCTY114) harbors a 2.4-kb XbaI fragment that bears a promoterless, albeit otherwise intact, SAC1 gene (Cleves et al., 1989) . The YCp(SAC1 ) plasmid carded by strain CTY443 (i.e., pCTY101) harbors a 7.5-kb Sstl-Sphl genomic DNA fragment that includes the entire SAC1 gene and the complete SAC1 promoter. Both pCTY101 and pCTYll4 carry URA3 as a selectable marker. (B) Quantitation of relative SACIp amounts. The corresponding yeast strains used in the immunofluorescence experiments described in the legend to Fig. 3 A were radiolabeled for 30 rain at 30°C, clarified extracts were prepared from the corresponding ~ precipitates, and SAClp and SEC14p immunoreactive materials were recovered by quantitative immunoprecipitation and resolved by SDS-PAGE and autoradiography. The SEC14p signal served to normalize the SAClp data. The lane designations correspond exactly to those in Fig. 3 A. gen alone, led to a complete loss of SAClp signal in wild-type yeast cells that were subjected to this immunofluorescence regimen (data not shown).
The nuclear envelope component of SAClp immunostaining became more pronounced when the amount of SAClp produced by yeast cells exceeded wild-type levels. Yeast strains CTY444 and CTY443 were engineered to exhibit a modest overproduction of the SAClp (see Materials and Methods). Quantitative immunoprecipitation analysis revealed that these strains overproduce SAClp some three-and sixfold relative to wild-type, respectively (Fig. 3 B, lanes 3  and 4) . Strain CTY444 exhibited a predominantly punctate SAClp-staining pattern that was very similar to that observed for wild-type cells, only more intense (Fig. 3 A, compare  lanes 2 and 3) . By contrast, when CTY443 was analyzed by immunofluorescence, both punctate and nuclear envelope SAClp-staining profiles were observed in essentially all of the ceils (Fig. 3 A, lane 4) . Comparison of the FITC-and DAPI-staining patterns recorded for strain CTY443 demonstrate coincidence of the nuclear envelope with SAClp staining. Furthermore, treatment of either wild-type or SAClpoverproducing yeast strains with cycloheximide for 1 h before fixation did not alter the corresponding SAClp localization profiles of these strains (not shown). Thus, no net chase of nuclear envelope SAClp staining into punctate staining was observed, nor vice versa. We currently interpret these data to suggest two compartments of steady-state residence for the SAClp in the yeast cell, and consider the nuclear envelope-associated SAClp staining to likely reflect some localization of this polypeptide to the yeast ER system. This conclusion is based on the similarity of this pattern of SAClp staining to the profile previously described for the lumenal ER marker KAR2p (Rose et al., 1989) , and is further supported by subcellular fractionation experiments (see below). We also note that, under conditions of modest SAClp overproduction, apparent SAClp staining of the plasma membrane could occasionally be observed (see Fig. 3 A, panel  4) . On the basis of experimental evidence presented below, Figure 4 . Double-label immunofluorescence staining of the filamentou s actin cytoskeleton and SAClp in yeast. Strain CTY443 was prepared for immunofluorescence as described in Materials and Methods. The F-actin cytoskeleton was stained with phalloidin conjugated to tetramethylrhodamine isothiocyanate (TRITC). The SAClp was visualized using an antibody sandwich consisting of anti-SAClp mAbs, rabbit anti-mouse IgG, and goat anti-rabbit IgG conjugated to fluorescein isothiocyanate (FITC). Nuclei and mitochondria were stained with DAPI. we believe this component of SAClp staining to reflect the presence of SAClp in the peripheral ER that lies immediately underneath the plasma membrane (Kaiser and Schekman, 1990) .
SAClp Does Not Detectably Associate with the Bulk of the Yeast F-Actin Cytoskeleton
To determine whether the punctate aspect of SAClp immunofluorescence staining represents localization of SAClp to plasma membrane-associated patches of filamentous-(F-) actin, termed cortical actin patches (Kilmartin and Adams, 1984) , we performed a series of double-label immunofluorescence experiments.
Yeast cells were fixed, permeabilized, and stained for SAClp by the antibody sandwich technique described above using an FITC-conjugated tertiary antibody. The cells were then co-stained with TRITC-conjugated phalloidin, a probe for F-actin. Visualization of the rhodamine staining profile of these wild-type yeast cells revealed the actin cables and cortical actin patches of the F-actin cytoskeleton in yeast (Fig. 4; Kilmartin and Adams, 1984) . The cortical actin patches are represented by the punctate F-actin staining that is prominently displayed in panels 1-3 of Fig. 4 . These cortical patches were not coincident with either the SAClp punctate staining profile, as determined by FITC fluorescence, or nuclear and mitochondrial staining, as determined by DAPI fluorescence. Furthermore, the actin cables, most prominently featured in panel 2, were not arranged in a manner that suggested some extensive association with SAClp punctare or perinuclear staining. These data indicate that: (a) SAClp was not localized to cortical actin patches, and (b) that SAClp did not exhibit some global association with the F-actin cytokeleton; at least not within the limits of detection of this technique. However, we were able to co-recover, in a SAClp-dependent manner, both SAClp and actin from cellfree lysates by native immunoprecipitation using either affinity-purified actln-specific antibodies or monoclonal SAClp antibodies as affinity probes (data not shown). The difficulties of absolutely excluding some artifactual corecovery of SAClp with the abundant actin polypeptide in such experiments, coupled with the failure of initial attempts to recover SAClp/actin complexes in cross-linking experiments, preclude a firm interpretation of those co-precipitation data. Nevertheless, such data leave open the possibility that SAClp associates with G-actin or actin oligomers in vivo.
SAClp Localizes to Yeast Goigi
To investigate the possibility that the punctate bodies stained with SAClp antibodies represent yeast Golgi bodies, we assessed the co-localization of SAClp with KEX2p, an integral membrane protein of the yeast Golgi (Franzusoff et al., 1991; Redding et al., 1991) . Strain CTY234, a KEX2p overproducing strain, was used for those studies. Fuller and colleagues have shown that yeast bearing the KEX2 gene on a multicopy plasmid exhibit normal localization for KEX2p, and that the amplified KEX2p staining can be readily detected without having to resort to antibody sandwich methods (Franzusoff et al., 1991; Redding et al., 1991) . To visualize KEX2p, fixed, and permeabilized cells of strain CTY234 were incubated with affinity-purified rabbit polyclonal anti-KEX2p serum and FITC-conjugated goat antirabbit IgG. SAClp was detected using an antibody sandwich consisting of primary anti-SAClp mouse mAbs, sheep antimouse IgG, and developed with Texas Red sulfonyl chloride (TRSC)-conjugated donkey anti-sheep IgG. Appropriate controls were performed to insure the specificity of the antisera and to verify the spectral separation of the fluorochromes under the photographic conditions employed (not shown). Fig. 5 shows representative cells from the '~100 cells that were examined in these studies. The upper panels show the punctate staining that is characteristic of KEX2p localization (Cleves et al., 1991; Franzusoff et al., 1991; Redding et al., 1991) , and the lower panels show the corresponding SAClp localization in the same cells. Inspection of these cells revealed a significant, but not absolute, coincidence of SAClp and KEX2p staining bodies (Fig. 5) Wild-type (CTY182) cells were grown at 25°C in YPD medium, converted to spheroplasts, and osmotic lysates prepared and fractionated essentially as previously described (Cleves et al., 1991) . The Pl00 fraction was further resolved by equilibrium flotation centrifugation in a 40-65 % sorbitol gradient and 1.0-ml fractions were collected from the top and assayed for the appropriate markers. The KEX2p peak fraction pool from this first gradient was designated the GRAD#1 fraction and was then further resolved by equilibrium sedimentation cantrifugation in a second 50-60% sorbitol gradient, 0.5-ml fractions were collected from the top, and analyzed for the indicated markers. The KEX2p peak fraction pool from this second gradient was designated as the GRAD#2 fraction, The relative quantities of KEX2p, SEC14p, and SAClp in each fraction were determined by quantitative ELISA (see Cleves et al., 1991b ) using 1.66/~g/ml, 5.7/~g/xnl, and 2.24/~g/rnl of antibody, respectively. Enzyme activities of the ER marker NADPH cytochrome c reductase (CC RED) are expressed as umoles of cytochrome c reduced per min per fraction. (B and C) Graphic representation of marker protein distribution across the first 40-65% and second 50-60% sorbitol gradients, respectively. markers, KEX2p and SEC14p, was assessed by a modification of a method we have previously described for obtaining highly enriched yeast Golgi fractions that are substantially free of contamination by the plasma membrane or ER, vacuolar, and mitochondrial membranes (Cleves et al., 1991b) . We also monitored the distribution of an ER marker, NADPH cytochrome c reductase, throughout the fractionation. The data presented in Fig. 6 A show that most of the KEX2p (68 % of total) was recovered in the P100 fraction. The SAClp, SEC14p, and cytochrome c reductase distributed more equally between the P12 and P100 membrane fractions. Further resolution of the P100 fraction by equilibrium flotation in a self-forming 40-65 % sorbitol gradient demonstrated coincidence of the peak KEX2p, SEC14p and SAClp fraction pools (Fig. 6 B) , containing 60, 18, and 45 % of total material, respectively. Moreover, satisfactory recoveries of antigen were obtained as 88, 86, and 94 % of input material was recovered from the peak fraction pools for KEX2p, SEC14p, and SAClp, respectively. Most of the cytochrome c reductase was recovered from denser fractions and some was pelleted to the bottom of the tube as well. Although the peak cytochrome c reductase fractions could be distinguished from the peak KEX2p, SEC14p and SAClp fractions (Fig. 6 B) , the fractions were pooled in such a manner that some 24 % of the total cytochrome c reductase was still present in the KEX2p/SEC14p/SAClp peak fraction. The final step involved resolution of the pooled membranes by equilibrium sedimentation in a self-forming 50-60 % sorbitol gradient. Again, the KEX2p, SEC14p and SAClp peak profiles in the sedimentation gradient were largely coincident (Fig. 6 C) although the SEC14p and SAClp peaks each exhibited a trail into lighter fractions whereas the KEX2p peak did not. Indeed, the SEC14p and SAClp peak profiles were nearly superimposable. Some 57 % of the total KEX2p (95 % of input) was recovered in the peak KEX2p fractions collected from this gradient, and 26% of the total SAClp (58% of input) was recovered in those KEX2p peak fractions. Approximately 94 % of the input SAClp was recovered in the SAClp-containing fractions of this gradient. Cytochrome c reductase sedimented quantitatively to the bottom of the gradient, and <1% of total reductase was recovered in the KEX2p peak fractions. Thus, a significant percentage of the total SAClp coemiched with the yeast Golgi integral membrane protein marker KEX2p and the peripheral Golgi protein SEC14p.
SAClp Also Resides in the Yeast ER
As approximately 50% of the total cellular SAClp was recovered in the P12 fraction, along with the majority of the ER and plasma membrane markers (i.e., NADPH cytochrome c reductase and plasma membrane ATPase, respectively; Fig. 6 B and Cleves et al., 1991b) , we further fractionated the P12 to assess the distribution of the SAClp with respect to ER and plasma membrane markers. The P12 was generated as described above, and determined to contain 54, 63, 43, and 8% of the total cytochrome c reductase, plasma membrane ATPase, SAClp, and KEX2p, respectively (data not shown). The P12 was then further resolved by equilibrium flotation in a self-forming 30-55 % sucrose gradient by the method of Bowser and Novick (1991) . Representative data are shown in Fig. 7 . In this system, we were able to partially resolve ER from plasma membrane fractions. The cytochrome c reductase was primarily localized to two distinct peaks. Approximately 20 % of the total cytochrome c reductase was recovered in the less dense peak pool (fractions 11-15), whereas 19% of the total was recovered in the denser peak pool (fractions [16] [17] [18] [19] . This 39 % recovery of total cytochrome c reductase in these two peaks represented a 91% recovery of enzyme loaded into the gradient. The plasma membrane ATPase fractionated in a single peak (fractions 18-22) that contained 31% of the total plasma membrane ATPase (49 % of input) and was denser than the ER peaks. The minor cellular fraction of KEX2p present in the P12 came offthe gradient in a single peak (fractions 9-12) that was less dense than any of the ER and plasma membrane peaks (Fig. 7) . These profiles are in good agreement with those reported by Bowser and Novick (1991) . SAClp was recovered primarily in a single peak that encompassed fractions 15-20 and contained 20% of total SAClp (48% of input). This peak coincided almost exactly with the denser of the two cytochrome c reductase peaks. Indeed, some 17% of the total cellular SAClp (40 % of input) was recovered in . SAClp cofractionates with ER membranes. P12 fractions were generated as described in the legend to Fig. 6 A, and the fraction of total intracellular NADPH cytochrome c reductase, vanadate sensitive plasma membrane ATPase, KEX2p, and SACIp in the P12 was determined as described (Cleves et al., 1991b) . The P12 was subsequently resolved by equilibrium flotation in a selfforming 30-55 % sucrose gradient by the method of Bowser and Novick (1991) , 0.5-ml fractions were collected from the top of the gradient to the bottom, and the various markers were quantitated in each fraction. The relative activities, or quantities, of each marker are expressed on a per 1-ml fraction.
the dense reductase pool (fractions 16-19) . A significant amount of SAClp (11% of total; 26 % of input) was recovered in the plasma membrane fractions as well (Fig. 7) . We note, however, that ,'~15% of total cytochrome c reductase (34% of input) was also recovered from those peak plasma membrane fractions (18) (19) (20) (21) (22) . As a result, the contamination of plasma membrane fractions by ER can fully account for SAClp detected in those fractions. Since we have failed to gain access to SAClp by protease shaving of intact spheroplasts, or by extrinsic labeling of surface exposed proteins by radioiodination methods (not shown), we consider the collective data to be most consistent with a localization of SAClp to a subfraction of ER membranes, in addition to Golgi membranes.
Suppression o f SEC14p and Actin Defects Occurs Through Loss o f SAClp Function
The sad null (sad °) phenotype is cold sensitivity for growth Cleves et al., 1989) . Since all of the available s a d alleles render the corresponding mutant strains cs for growth, regardless of whether these alleles were initially identified as suppressors of actl-1 ~ or of sec14-1% it seems likely that suppression in both cases involves loss of SAClp function. However, the finding that sac1 ° mutations result in a phenotypicaily less efficient suppression of act1-1 ~ or sec14-1 ~ lesions has prompted the suggestion that suppressor sad ~ alleles attenuate, but may not eliminate, SAClp function Cleves et al., 1989) . As a resolution of this issue is crucial to the understanding of how SAClp relates to both actin and Golgi function in yeast, we wished to examine this point further by analyzing the SAClp profile from 21 representative sacl cs strains. Fourteen of the corresponding alleles were isolated as suppressors of seal4-1 '~ whereas the remaining seven were identified as suppressors of actl-1 ~. The appropriate strains were radiolabeled for 1 h at 30°C with 3sS-labeled amino acids, SAClp and SEC14p immunoreactive materials were recovered, and the products were analyzed by SDS-PAGE, and autoradiography. The SEC14p signal served to normalize the SAClp data. The sac1" mutations fall into three general classes with respect to the form of SAClp that was detected in lysates prepared from the corresponding mutants. Representative data for each of these classes are shown in Fig. 8 A, while a comprehensive tabulation of the data is presented in Fig. 8 B. Class I is represented by six sac1 cs alleles and the corresponding mutants exhibited a form of SAClp that, by SDS-PAGE, was indistinguishable from wild-type SAClp. Moreover, the amount of SAClp antigen recovered from the class I mutants was not significantly reduced relative to that recovered from the wild-type strain. Class II mutants, however, produced a truncated form of SAClp, and four s a d " alleles fall into this category. The SAClp species encoded by the three class II alleles represented in Fig. 8 A ( i.e., sac1-6 ~, sad-11", sacl-14 ") exhibited molecular masses of "~53 kD, 52 kD, and 55 kD, respectively. Finally, the remaining 11 s a d " alleles define the class IN category. The corresponding mutants failed to produce detectable SAClp antigen under the radiolabeling conditions described. Since these experiments involved a relatively long period of radiolabeling (1 h), we have also attempted to visualize SAClp antigen in class 1/I mutants under conditions of pulse-radiolabeling. We have used pulse radiolabels of as short as 5 min and still have failed to detect SAClp antigen in those mutant lysates. This inability to detect SAClp antigen in class HI s a d " strains is considered significant as the wild-type SAClp exhibits a half-life of ,',,1 h at 30°C (not shown). The simplest interpretation of these collective data is that the class HI sac1 ~ alleles are essentially equivalent to sad* alleles, and these data are most consistent with a model in which the mechanism of act1-1 ~ and sec14-1 ~ suppression involves loss of SAClp function. This model predicts that sac1 disruption mutations should result in a bypass of the normally essential SEC14p requirement and, consequently, a suppression of secl4 disruption alleles. This prediction was fulfilled by our ability to directly transplace the haploid-lethal seal4-129:: HIS3 disruption (described in Bankaitis et al., 1989) into s a d ° haploid strains by transformation.
Suppression o f SEC14p Defects is not a General Property o f Mutations in SAC Genes
Previous work has identified other SAC genes, clearly distinct from SAC1, whose products represent candidate actin binding proteins Dunn and Shortle, 1990; Adams et al. 1989) . As in the case of SAC1, the SAC2 and SAC3 genes were identified on the basis of the isolation of cs mutations that exhibit a recessive and allele-specific suppression of act1 ~ mutations . SAC7 was similarly identified in an actin suppressor screen and, while suppressor sac7 alleles exhibit both co-dominant and recessive phenotypic traits, both the allele-specificity of the suppression of actin mutations and the synthetic lethality associated with specific combinations of sac7 and act1 ~ alleles closely resembles the genetic interactions observed between sac1 and act1 ~ alleles (Dunn and Shortle, 1990) . SAC6 was identified in a screen for dominant suppressors of act1 ~ . Penetrating insights into the mechanism of function have been obtained for only one of these gene products. Adams et al. (1989) have provided strong evidence to indicate that the SAC6p is the yeast version of the actin bundling protein fimbrin. To determine if phenotypic suppression ofsecl4 mutations is a general property of sac mutations, we combined the appropriate sac alleles with defined sec14 alleles in haploid yeast and then scored phenotypic suppression of secl4 defects.
The data show sacl alleles to be unique in their ability to suppress sec14 defects. Introduction of the dominant suppressor of actin allele sac6-2 had no effect on the cellular requirement for SEC14p function as evidenced by the failure of this dominant sac6-2 allele to effect any detectable phenotypic suppression of sec14-1 ~ or sec14Zkl::HIS3. Suppression of the normally lethal sec14~l::HIS3 lesion was assessed by a plasmid shuffle/colony sectoring assay that tested whether a yeast centromeric plasmid bearing the sac6-2 allele (i.e., pAAB162; see Adams et al., 1989 ) was able to relieve the dependence of a sed4Al::HIS3 strain (CTY558 ;  Table I ) on the presence of a SEC14 plasmid for viability (not shown). The recessive suppressor of actin alleles sac2d" and sac3-1" also failed to phenotypically suppress sec14-1'*, as judged by the uniform 2:2 segregation of Ts+/Ts -phenotypes in the meiotic progeny obtained from each of the 10 and 12 asci analyzed from genetic crosses where sec14-1 ~ and sac24", and sec14-1 ~ and sac3-1" were segregating, respectively. If these sac'* alleles were to suppress sec14-1 ~, we would have expected the majority (ca. 75%) of asci to have yielded greater than two "Is ÷ meiotic progeny apiece. Moreover, we readily recovered sec14-1 #, sac'* double mutant meiotic progeny from these crosses, as identified by their dual ts,cs phenotypes. Finally, a sacTAI::URA3 null allele (see Materials and Methods), an allele that is directly analagous to a sacZ':LEU2 disruption allele shown by Dunn and Shortle (1990) to suppress actin defects, also was unable to effect a phenotypic suppression of either sec14-1 ~ or sed4z~l::HIS3. Again, suppression of the latter was assessed by testing whether a genomic sacTAI::URA3 allele could relieve the dependence of a sed4~l::HIS3 strain (CTY558; see Table I ) on the presence of a SEC14 plasmid for viability. Suppression of sec14-P was assessed by transplacement of sac7~l::URA3 into a haploid sec14-1 ~ strain (CTYI-IA; Table I) and scoring the desired recombinants for phenotypic suppression of sec14-1 # (see Materials and Methods).
Thus, sad alleles are unique with respect to their ability to suppress both specific actin defects and wholesale defects in SEC14p function. The distinction between sac1 and sac7 mutations in this regard is especially noteworthy as sac1 and sac7 mutations exhibit a very similar allele specificity not only with respect to which actin mutations these suppress (i.e., actl-l#), but also with respect to which actin mutations (i.e., act1-2 ~) result in synthetic lethality when combined with these sac mutations in a haploid yeast cell Dunn and Shortle, 1990) .
sac1 Mutants are Inositol Auxotrophs
During the course of these studies, we noted that sac1 mutants fail to grow in inositol-free media. As wild-type yeast strains have de novo inositol biosynthetic capability, this inositol auxotrophy represents a new sacl-associated phenotype and is illustrated in Fig. 9 A. The growth characteristics of a number of sac1 strains on inositol-free and inositol supplemented media were compared to those of a SAC1 strain and a known inositol auxotrophic strain (ino1-13). The inol-13 strain is deficient in inositol-l-phosphate synthase activity and fails to convert glucose-6-phosphate to inositol-1-phosphate, a direct intermediate in inositol biosynthesis in yeast (for a review see Carman and Henry, 1990) . The data indicate that: (a) sac1 strains failed to grow (i.e., form isolated colonies) on inositol-free medium; (b) the severity of this growth defect closely resembled that of the ino1-13 mutant; and (c) this growth defect was inositol remedial. The growth capabilities of the other sac mutants were also tested on media either containing or lacking inositol. The data are presented in Fig. 9 B. Clearly, all of the other sac mutants exhibited rather normal growth properties irrespective of the inositol content of the media. These phenotypic data indicate that sac1 mutants are unique among the sac mutants not only in their suppression of sec14 defects, but also in their inositol auxotrophy.
Measurement of Intracellular Inositol Pools in sac1 Mutants
Several indirect lines of evidence suggested that the inositol auxotrophy associated with sac1 mutations was not likely to be the simple result of an inositol biosynthetic defect. Genetic mapping and nucleotide sequence data indicate that the structural genes for: (a) yeast inositol-l-phosphate synthase (IN01); (b) the transcriptional activators of IN01 (i.e., IN02 and IN04); and (c) SAC1, are clearly distinct (Donahue and Henry, 1981; Klig and Henry, 1984; Novick et al., 1989; Cleves et al., 1989; Hoshizaki et al., 1990; Nikoloff et al., 1992) . Second, the ino1-13 allele fails to suppress sec14-1 ~ and does not manifest itself in a cs growth phenotype (not shown). Finally, the cs growth defects and suppressor phenotypes associated with sacl mutations are manifested in media containing sufficient inositol to overcome any inositol biosynthetic defects.
To more directly assess whether sad mutants suffer an intracellular inositol deficit when shifted to inositol-free media, we measured intracelhlar inositol pools in wild-type, inol, and sad mutant strains as a function of inositol deprivation. As shown by the data in Fig. 10 A, the intracelhlar inositol pools of the wild-type, ino1-13, and sacl-26 mutant strains immediately after shift to inositol-free medium were of similar magnitude, ranging from •2.5 moles inositol//~g protein in the case of the wild-type and ino1-13 strains down to 2.0 moles inositol/#g protein for the sacl-26mutant. Although these values were quite similar, we note that the inosi- tol pools of the sacl-26 mutant were slightly, but reproducibly, lower than those of the wild-type and ino1-13 strains. At this time we do not consider this to be a significant difference. Deprivation of wild-type cells for exogenous inositol for a 3-h period had no significant effect on intracellular inositol pools. In marked contrast, similar challenge of the inol-13 mutant resulted in almost a 6-fold reduction in its inositol pools relative to those measured for this strain immediately after shift into inositol-frcc medium (Fig. I0 A) . We presume that this loss of inositol pool homeostasis was a manifestation of the inol-13-associated inositol biosynthetic defect. As in the case of the wild-type strain, a 3 h inositol deprivation did not elicit any appreciable reduction in the inositol pools of the sacl-26mutant strain (Fig. 10 A) . From these data we infer that sacl mutants were not defective in were grown in inositol supplemented minimal defined medium and subsequently shifted to inositol-free medium. Samples were harvested immediately after shift (0 rain) and at 180 rain postshift, and the inositol pools of the cells collected at each time point were determined for each strain as indicated (see Materials and Methods). Values for the 0 rain sample are represented by the solid black bars whereas the 180-rain samples are represented by the stippled bars. (B) Bulk membrane glycerophospholipid composition of wild-type and ~sac/strains at steady state. Yeast strains CTY182 (wild-type) and were cultured in YPD. Total glyeerophospholipid was subsequently extracted, resolved into individual species by two-dimensional chromatography, and the phosphate content of each species quantitated by chemical assay. The data for each individual phospholipid species are presented as mole % of the indicated species measured relative to total glycerophospholipid plus phosphate remaining at the origin. Values for the wildtype strain are represented by the solid black bars whereas the ~sac/ values are represented by the stippled bars. Phospholipid species are indicated as phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylcholine (PC), and phosphatidylethanolamine (PE).
B u l k Membranes Prepared From sacl Mutants Exhibit a Normal Phosphatidylinositol Content
To determine whether sac1 mutants are somehow defective in the incorporation of inositol into PI, we compared the glycerophospholipid composition of bulk membranes prepared from wild-type and Asac/yeast. In these experiments, cells were cultured in YPD, an inositol-containing medium, total glycerophospholipids were extracted from the cells, displayed by two-dimensional paper chromatography, and individual glycerophospholipid species recovered and quantitated by inorganic phosphate assay (see Materials and Methods) . As demonstrated by the data in Fig. 10 B, the steady-state bulk membrane glycerophospholipid compositions of the wild-type and ~sacl mutant strains were very similar. Indeed, both strains exhibited essentially the same PI content as a function of total glycerophospholipid (ca. 22 mole%). Similar results were obtained when these same strains were radiolabeled to steady-state with p2p]orthophosphate in phosphate-depleted YPD. Additional [32p] orthophosphate pulse-radiolabeling experiments (30-min pulse) in phosphate-depleted YPD medium also failed to reveal obvious differences in bulk membrane PI content between wild-type and ~sac/strains (not shown). These data suggest that sac1 mutants were not grossly impaired in their ability to incorporate inositol into PI, and that sac1 mutants did not experience wholesale defects in PL metabolism.
Discussion
Our data indicate a physical association of SAClp with compartments of the secretory pathway. First, immunoprecipitation experiments identified SAClp as an inabundant and unglycosylated protein with an apparent molecular mass of 65 kD (Fig. 1) . Second, subeellular fractionation experiments demonstrated that SAClp quantitatively sedimented with membranes ( Fig. 2 A) . Moreover, we found that SAClp was not extracted from membranes by alkaline Na:CO3 treatment (Fig. 2 B) and, in other solubilization experiments, we observed that SAClp efficiently partitioned into a Triton X-114 detergent phase. These data indicate that SAClp is an integral membrane protein. Third, immunofluoreseenee analyzes revealed a predominantly punctate pattern for SAClp staining in wild-type cells (Fig. 3 A, lane 2) . Double-label fluorescence experiments indicated a substantial colocalization of the punctate SAClp staining with structures stained with probes specific for KEX2p, a resident polypeptide of yeast Golgi membranes (Fig. 5) , and biochemical fractionation data confirmed a significant presence of SAClp in highly enriched Golgi fractions ( Fig. 6 ; see above). Since it is the Golgi complex that is dysfunctional in sec14 strains, and sad mutations effect a bypass of the normally essential SEC14p requirement for yeast Golgi secretory function, these data suggest that SAClp exerts a local effect on the secretory competence of yeast Golgi membranes. We note, however, that SAClp-specific staining of what appears to be the yeast ER was also observed and that the prominence of this staining increased in direct proportion to the intraeellular levels of SAClp (Fig. 3 A) . Subeellular fractionation experiments further confirmed the presence of SAClp in a subfraction of ER membranes prepared from wild-type cells (Fig. 7) . Thus, SAClp exhibits a steady-state residence in the yeast Golgi complex and in the yeast ER. The latter component of SAClp localization may provide some physical basis for the negative genetic interactions that have been observed between sad c" alleles and several sec mutations that block protein transport through early stages of the secretory pathway (Cleves et ai., 1989) . With regard to whether SACIp associates with actin, we found that SAClp staining was not ob-viously coincident with that of cortical actin patches or actin cables (Fig. 4) . Thus, the present data do not support models invoking some global association of SAClp with the F-actin cytoskeleton. However, our ability to coprecipitate SAClp and actin in native immunoprecipitation experiments still leaves open the possibility that SAClp may associate with G-actin or actin oligomers in vivo (see above).
How can the various data be incorporated into a model for SAClp function in vivo? Clearly, it is the loss of SAClp function that results in the bypass of the normally essential SEC14p requirement and in the suppression of act1-1 ~ (Fig.  8) . These data indicate that SAClp function is, in principle, antagonistic to both Golgi secretory function and some aspect of actin function (perhaps actin assembly) in yeast. Finally, the ability of sad alleles to cosuppress both actin and sec14 defects is a feature that is unique to sad as this character was not exhibited by the several other suppressor of actin sac alleles we have tested. For this reason, we believe that the mechanism of suppression, by SAClp dysfunction, of actin and SEC14p defects includes features that are unique to the sad mechanism, and are not shared by the suppression mechanisms operating in the other sac mutants we have tested. We assign considerable relevance to the specific inositol auxotrophy exhibited by sad yeast strains not only because this phenotype correlated with suppression of sec14 defects in the survey of sac mutants (Fig. 9 ), but also because a similar inositol auxotrophy is associated with another suppressor of sec14 defects. The bsd2-1 mutation represents a dominant bypass suppressor of sec14 defects (Cleves et al., 1991b) . This allele also phenotypically manifests itself in an inositol auxotrophy that is itself a dominant trait (T. P. McGee, and V. A. Bankaitis, unpublished data). The finding that inositol auxotrophy is a phenotype shared by two distinct classes of mutations that suppress sec14 defects suggests that this inositol auxotrophy is somehow reflective of the mechanism by which sec14 and actin defects are suppressed in sad strains.
What possible clues might the sad-associated inositol auxotrophy provide with respect to SAClp function in cells and how SAClp dysfunction may influence the organization of the actin cytoskeleton and the cellular requirement for SEC14p? As inositol is a direct precursor of the essential glycerophospholipid PI, which itself provides the inositol moiety in the biosynthesis of inositol sphingolipids (Becker and Lester, 1980) , the inositol auxotrophy suggests some relationship between SAClp function and inositol glycerophospholipid metabolism. It may be relevant that the mammalian actin binding proteins profilin, gelsolin and cofilin exhibit a high affinity binding of phosphoinositides in vitro (Goldschmidt-Clermont et al., 1990; Lassing and Lindberg, 1985; Yin et al., 1988; Yonezawa et al., 1991) . Pollard and co-workers have obtained some biochemical evidence to support the notion that the cytosolic protein profilin sequesters phosphatidylinositol 4,5-bisphosphate (PIP2), thus rendering the bound PIP2 inaccessible to degradation by unstimulated phospholipase C (Goldschmidt-Clermont et al., 1991) . These findings suggest a biochemical link between polyphosphoinositides, direct derivatives of the preferred in vitro ligand of the SEC14p (i.e., PI; Daum and Paltauf, 1984) , and the regulation of actin assembly.
The notion that SAClp function somehow interfaces with inositol glycerophospholipids is an attractive one as it suggests a general explanation, within an already familiar conceptual framework, for several of the outstanding phenotypes associated with the loss of SAClp function (i.e., suppression of act1-1 ~ and sec14 mutations, a novel inositol auxotrophy, and a dramatic disorganization of the actin cytoskeleton in sad cells challenged with low temperatures). The demonstration that sac1-26 mutants maintained substantially normal intracellular inositol pools in the face of challenge with inositol-free medium suggests that sad mutants retain wild-type de novo inositol biosynthetic capability (Fig. 10 A) . Thus, it seems unlikely that the saclassociated inositol auxotrophy is the result of an inositol biosynthetic defect. As the data also failed to indicate an obvious inositol utilization defect in Asad mutants (Fig. 10 B) , it seems most likely that sac1 mutants require elevated levels of inositol for cell growth. An elevated inositol requirement might reflect some unusual turnover of inositol phospholipids in sad mutants, perhaps due to the loss of some SAClpdependent inositol phospholipid sequestration function. The finding that bulk membrane PI levels of Asad mutants were indistinguishable from those of wild-type strains, however, does not reveal a wholesale defect in PI metabolism in sad mutants (Fig. 10 B) . It will be of interest to determine whether sad mutations affect the PI content of yeast Golgi membranes.
The idea that SAClp functions in inositol phospholipid sequestration has some important ramifications for the genetic (i.e., allele specificity) argument that SAClp is a candidate actin binding protein. If SAClp is involved in regulating (i.e., antagonizing) inositol PL turnover in cells, it need not exhibit a physical association with actin in order for loss of SAClp function to phenotypically manifest itself either in the observed disorganization of the actin cytoskeleton in vivo or in the observed allele-specific genetic interactions with act1 mutations. For example, loss of SAClp function might upset the normal function of other actin binding proteins that interact with actin in an inositol phospholipid-sensitive manner; thereby eliciting the observed allele-specific effects on actin cytoskeleton function and organization in cells via an indirect lipid-mediated effect. In this scenario, deregulated inositol PL turnover in sad mutants could suppress actin defects associated with inefficient polymerization of mutant G-actin monomers, yet further exacerbate actin defects associated with inefficient disassembly of mutant F-actin structures. It is interesting to note that actl-l,, a mutation suppressed by sad, has been suggested to encode polymerization-defective actin whereas act1-2 ~, a mutation that exhibits synthetic lethality with sad, has been proposed to result in the formation of disassembly-defective F-actin structures . Such a model describes a situation where a remarkable allele specificity might be generated not as a result of altered protein-protein interactions between two mutant polypeptides but, rather, from a more indirect alteration in the regulation of the assembly of one of the mutant polypeptides. Alternatively, if SAClp itself binds G-actin in an inositol PL-sensitive manner, the various sac1 effects on the organization of the actin cytoskeleton and the accompanying sad-act1 genetic interactions can be accommodated into a model directly analagous to the profilin paradigm as proposed by Goldschmidt-Clermont et al. (1991) .
The data presented in this report also offer interesting pos-sibilities with regard to what SEC14p-dependent biochemical functions might determine the secretory competence of yeast Golgi membranes. Our previous results have suggested that PC synthesis via the CDP-choline pathway is not compatible with Golgi secretory function in vivo, and that the essential role of SEC14p is to moderate the antagonism between these two cellular functions by maintaining an appropriate phospholipid composition in yeast Golgi membranes (Cleves et al, 1991a, b) . One implication of those data is that excess PC is detrimental to Golgi secretory function. The general models for SAClp function entertained here raise the alternative, but not mutually exclusive, possibility of a SEC14p-dependent involvement of inositol phospholipids, or perhaps the local turnover of such phospholipids, in yeast Golgi secretory function.
